PedAM
Pediatric Disease Annotations & Medicines
| Disease | schizophrenia |
| Phenotype | C0012236|22q11.2 deletion syndrome |
| Sentences | 10 |
| PubMedID- 25484875 | Microrna dysregulation, gene networks, and risk for schizophrenia in 22q11.2 deletion syndrome. |
| PubMedID- 20485477 | Small chromosomal aberrations (copy number variations, genomic imbalances) may confer a risk for schizophrenia, as with the 22q11.2 deletion syndrome (22q11.2 ds). |
| PubMedID- 21475728 | How might stress contribute to increased risk for schizophrenia in children with chromosome 22q11.2 deletion syndrome? |
| PubMedID- 22078159 | The second finding is the association of schizophrenia with 22q11.2 deletion syndrome (22q11.2ds; also known as velo-cardio-facial syndrome), which has an incidence of 1 in approximately 4,000 live births and leads to a varied set of symptoms, including physical defects and learning disabilities. |
| PubMedID- 26087175 | Fetal growth and gestational factors as predictors of schizophrenia in 22q11.2 deletion syndrome. |
| PubMedID- 24262682 | Premorbid adjustment and schizophrenia in individuals with 22q11.2 deletion syndrome. |
| PubMedID- 23248646 | Mirna-mediated risk for schizophrenia in 22q11.2 deletion syndrome. |
| PubMedID- 21362743 | Association of schizophrenia in 22q11.2 deletion syndrome and gray matter volumetric deficits in the superior temporal gyrus. |
| PubMedID- 23916466 | Background: 22q11.2 deletion syndrome (22q11ds) associates with schizophrenia spectrum disorders (ssds), autism spectrum disorders (asds), and other psychiatric disorders, but co-occurrence of diagnoses are not well described. |
| PubMedID- 24534796 | Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome. |
Page: 1